HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SINOMAB BIO-B

1.200

-0.070-5.51%

Volume:1.01M

Turnover:1.26M

Market Cap:1.66B

PE:-12.06

High:1.320

Open:1.305

Low:1.200

Close:1.270

52wk High:3.630

52wk Low:0.990

Shares:1.39B

HK Float Shares:1.39B

Volume Ratio:0.89

T/O Rate:0.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.099

ROE:-29.96%

ROA:-9.63%

PB:2.82

PE(LYR):-12.06

PS:249.90

Loading ...

Overview Company News Filings

Revised Title

Sinomab Bioscience posts unchanged share capital and maintains public float in April 2026 monthly return

Bulletin Express

SinoMab BioScience releases 2025 ESG report

SinoMab BioScience unveils 2026 AGM agenda: board changes, 10% share buy-back mandate and 20% issuance limit

Bulletin Express

SinoMab BioScience announces annual general meeting

SinoMab BioScience publishes 2025 annual report

君实生物（SINOMAB BIO-B）2025年显著减亏，股本增长强化资金实力

Bulletin Express

Sinomab Bioscience Maintains 1.39 Billion Outstanding Shares in March 2026, Grants 11.57 Million New Options

Bulletin Express

BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience

Hainan Haiyao Says Co Plans to Unload up to 5% Stake in SinoMab BioScience Ltd

THOMSON REUTERS

SM17 Phase 2 Trial for Atopic Dermatitis Administers First Dose in China

SinoMab doses first patient in China Phase 2 trial of SM17 for atopic dermatitis

SinoMab BioScience says non-executive directors Chen, Dong resign

SinoMab BioScience files list of directors with Hong Kong Stock Exchange

SinoMab Announces Resignation of Two Non-Executive Directors Effective March–April 2026

Bulletin Express

SinoMab Announces Updated Board Composition and Committee Assignments

Bulletin Express

SINOMAB BIO-B Announces Resignation of Non-Executive Director

SinoMab Announces Positive Phase 1 Bridging Data for Subcutaneous SM17, Preparing Phase 2 Atopic Dermatitis Trial

Bulletin Express

Positive Topline Results from SM17 Route Conversion Phase 1 Bridging Study in China

SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/03681/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03681","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03681\",,,,,undefined,":{"symbol":"03681","market":"HK","secType":"STK","nameCN":"SINOMAB BIO-B","latestPrice":1.2,"timestamp":1786519382935,"preClose":1.27,"halted":0,"volume":1014900,"delay":0,"changeRate":-0.05511811023622052,"floatShares":1387000000,"shares":1387000000,"eps":-0.09948846932529781,"marketStatus":"Trading","change":-0.07,"latestTime":"08-12 15:23:31","open":1.305,"high":1.32,"low":1.2,"amount":1256068,"amplitude":0.094488,"askPrice":1.22,"askSize":5100,"bidPrice":1.195,"bidSize":18300,"shortable":0,"etf":0,"ttmEps":-0.09768821507603938,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1786522200000},"marketStatusCode":2,"adr":0,"listingDate":1573488000000,"exchange":"SEHK","adjPreClose":1.27,"openAndCloseTimeList":[[1786498200000,1786507200000],[1786510800000,1786521600000]],"volumeRatio":0.894437,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03681\",,,,,undefined,":{"symbol":"03681","floatShares":1387000000,"roa":"-9.63%","roe":"-29.96%","lyrEps":-0.099488,"volumeRatio":0.894437,"shares":1387000000,"dividePrice":0,"high":1.32,"amplitude":0.094488,"preClose":1.27,"low":1.2,"week52Low":0.99,"pbRate":"2.82","psRate":"249.90","week52High":3.63,"institutionHeld":0,"latestPrice":1.2,"committee":0.564103,"eps":-0.09948846932529781,"divideRate":0,"volume":1014900,"delay":0,"ttmEps":-0.09768821507603938,"open":1.305,"prevYearClose":1.34,"prevWeekClose":1.34,"prevMonthClose":1.36,"prevQuarterClose":1.01,"fiveDayClose":1.345,"twentyDayClose":1.22,"sixtyDayClose":1.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03681\",params:#limit:5,,,undefined,":[{"date":"2026-03-23","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null},{"date":"2025-08-29","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null},{"date":"2025-03-31","symbol":"03681","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743384600000,"name":null,"time":"Post-Mkt","dateTimestamp":1743350400000,"actualEps":null},{"date":"2024-08-19","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"03681","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03681\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03681\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03681\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03681","date":"2026-08-11","current":-12.746705,"percent":0.224456,"low":-23.455488,"twenty":-14.723694,"median":-6.562246,"eighty":-5.465196,"high":-3.722923,"avg":-9.311542,"sd":4.727055,"marketCap":1761030686},"quantilePoints":[{"date":"2021-08-13","current":-13.294749,"twenty":-13.777264,"median":-12.496503,"eighty":-11.523175,"marketCap":3461466976},{"date":"2021-08-20","current":-13.255016,"twenty":-13.773808,"median":-12.685303,"eighty":-11.644555,"marketCap":3441342168},{"date":"2021-08-27","current":-17.669121,"twenty":-13.975785,"median":-12.738418,"eighty":-11.743407,"marketCap":3320593320},{"date":"2021-09-03","current":-17.554902,"twenty":-14.338065,"median":-12.760766,"eighty":-11.775878,"marketCap":3300468512},{"date":"2021-09-10","current":-16.976031,"twenty":-17.456016,"median":-12.775475,"eighty":-11.78116,"marketCap":3199844472},{"date":"2021-09-17","current":-16.651593,"twenty":-17.163126,"median":-12.813689,"eighty":-11.784078,"marketCap":3129407644},{"date":"2021-09-24","current":-16.322789,"twenty":-17.01345,"median":-12.863899,"eighty":-11.803908,"marketCap":3069033220},{"date":"2021-09-30","current":-15.62828,"twenty":-16.889918,"median":-12.933105,"eighty":-11.815139,"marketCap":2948284372},{"date":"2021-10-08","current":-15.255604,"twenty":-16.819086,"median":-13.000983,"eighty":-11.827705,"marketCap":2877847544},{"date":"2021-10-15","current":-15.72489,"twenty":-16.74672,"median":-13.132604,"eighty":-11.837118,"marketCap":2968409180},{"date":"2021-10-22","current":-15.401098,"twenty":-16.540959,"median":-13.171977,"eighty":-11.85164,"marketCap":2928159564},{"date":"2021-10-29","current":-15.227051,"twenty":-16.374107,"median":-13.199196,"eighty":-11.878327,"marketCap":2887909948},{"date":"2021-11-05","current":-14.725283,"twenty":-16.372621,"median":-13.237809,"eighty":-11.89956,"marketCap":2797348312},{"date":"2021-11-12","current":-14.61207,"twenty":-16.352569,"median":-13.315659,"eighty":-11.914333,"marketCap":2787285908},{"date":"2021-11-19","current":-15.742119,"twenty":-16.272521,"median":-13.361795,"eighty":-11.935532,"marketCap":2998596392},{"date":"2021-11-26","current":-16.370792,"twenty":-16.351591,"median":-13.392935,"eighty":-11.980901,"marketCap":3119345240},{"date":"2021-12-03","current":-15.286348,"twenty":-16.351591,"median":-13.405799,"eighty":-12.04665,"marketCap":2918097160},{"date":"2021-12-10","current":-15.733887,"twenty":-16.272521,"median":-13.447456,"eighty":-12.050361,"marketCap":3008658796},{"date":"2021-12-17","current":-15.639454,"twenty":-16.187564,"median":-13.518433,"eighty":-12.058984,"marketCap":2988533988},{"date":"2021-12-24","current":-14.782807,"twenty":-16.164329,"median":-13.528315,"eighty":-12.072918,"marketCap":2827535524},{"date":"2021-12-31","current":-15.013189,"twenty":-16.148278,"median":-13.610066,"eighty":-12.088245,"marketCap":2877847544},{"date":"2022-01-07","current":-15.18328,"twenty":-56.995184,"median":-15.257327,"eighty":-11.069992,"marketCap":2897972352},{"date":"2022-01-14","current":-13.838759,"twenty":-56.661206,"median":-15.253171,"eighty":-11.083158,"marketCap":2646412252},{"date":"2022-01-21","current":-14.011082,"twenty":-56.563091,"median":-15.205087,"eighty":-11.097021,"marketCap":2686661868},{"date":"2022-01-28","current":-13.844706,"twenty":-56.416081,"median":-15.162616,"eighty":-11.110592,"marketCap":2646412252},{"date":"2022-02-04","current":-14.147107,"twenty":-56.354717,"median":-15.132267,"eighty":-11.116336,"marketCap":2706786676},{"date":"2022-02-11","current":-14.606007,"twenty":-56.147197,"median":-15.118177,"eighty":-11.129988,"marketCap":2797348312},{"date":"2022-02-18","current":-14.139516,"twenty":-55.690459,"median":-15.086325,"eighty":-11.142948,"marketCap":2716849080},{"date":"2022-02-25","current":-13.42323,"twenty":-55.257879,"median":-15.019949,"eighty":-11.15276,"marketCap":2586037828},{"date":"2022-03-04","current":-13.026991,"twenty":-53.858211,"median":-14.992767,"eighty":-11.16401,"marketCap":2515601000},{"date":"2022-03-11","current":-11.331852,"twenty":-51.77227,"median":-14.946362,"eighty":-11.15276,"marketCap":2183541668},{"date":"2022-03-18","current":-10.950696,"twenty":-51.706305,"median":-14.891162,"eighty":-11.138994,"marketCap":2103042436},{"date":"2022-03-25","current":-6.331043,"twenty":-51.516242,"median":-14.885049,"eighty":-11.102449,"marketCap":2243916092},{"date":"2022-04-01","current":-6.444111,"twenty":-51.096665,"median":-14.824593,"eighty":-11.058409,"marketCap":2294228112},{"date":"2022-04-08","current":-6.459624,"twenty":-46.359849,"median":-14.790242,"eighty":-11.033253,"marketCap":2294228112},{"date":"2022-04-14","current":-5.956258,"twenty":-29.052376,"median":-14.738629,"eighty":-11.016253,"marketCap":2113104840},{"date":"2022-04-22","current":-6.201306,"twenty":-29.037222,"median":-14.692829,"eighty":-10.958063,"marketCap":2173479264},{"date":"2022-04-29","current":-7.047751,"twenty":-28.4902,"median":-14.61207,"eighty":-10.874053,"marketCap":2404914556},{"date":"2022-05-06","current":-7.40055,"twenty":-28.325538,"median":-14.600612,"eighty":-10.804339,"marketCap":2515601000},{"date":"2022-05-13","current":-6.941182,"twenty":-28.290262,"median":-14.594456,"eighty":-10.722043,"marketCap":2314352920},{"date":"2022-05-20","current":-7.047867,"twenty":-28.237839,"median":-14.568039,"eighty":-10.643776,"marketCap":2374727344},{"date":"2022-05-27","current":-6.144605,"twenty":-28.156235,"median":-14.531177,"eighty":-10.62065,"marketCap":2062792820},{"date":"2022-06-02","current":-6.336579,"twenty":-27.976109,"median":-14.467448,"eighty":-10.551157,"marketCap":2143292052},{"date":"2022-06-10","current":-5.805638,"twenty":-27.48092,"median":-14.330061,"eighty":-10.395661,"marketCap":1962168780},{"date":"2022-06-17","current":-6.023844,"twenty":-27.416382,"median":-14.289989,"eighty":-10.295871,"marketCap":2032605608},{"date":"2022-06-24","current":-5.928927,"twenty":-27.299726,"median":-14.240631,"eighty":-10.21101,"marketCap":2002418396},{"date":"2022-06-30","current":-5.933518,"twenty":-27.286301,"median":-14.178121,"eighty":-10.034927,"marketCap":2002418396},{"date":"2022-07-08","current":-6.051704,"twenty":-27.219437,"median":-14.139516,"eighty":-9.92976,"marketCap":2042668012},{"date":"2022-07-15","current":-6.160189,"twenty":-27.207128,"median":-14.122793,"eighty":-9.645343,"marketCap":2062792820},{"date":"2022-07-22","current":-6.38092,"twenty":-27.106743,"median":-14.101553,"eighty":-9.560125,"marketCap":2133229648},{"date":"2022-07-29","current":-6.359757,"twenty":-26.964443,"median":-14.083303,"eighty":-9.205273,"marketCap":2133229648},{"date":"2022-08-05","current":-6.154173,"twenty":-26.908811,"median":-14.068582,"eighty":-8.936804,"marketCap":2062792820},{"date":"2022-08-29","current":-5.022866,"twenty":-26.892677,"median":-14.039832,"eighty":-8.916691,"marketCap":1821295124},{"date":"2022-09-23","current":-5.142672,"twenty":-26.844273,"median":-13.982946,"eighty":-8.833147,"marketCap":1811232720},{"date":"2022-09-30","current":-5.173446,"twenty":-26.611125,"median":-13.901548,"eighty":-8.524333,"marketCap":1811232720},{"date":"2022-10-07","current":-5.226001,"twenty":-26.521278,"median":-13.841732,"eighty":-8.358846,"marketCap":1831357528},{"date":"2022-10-14","current":-5.210526,"twenty":-26.305402,"median":-13.711835,"eighty":-8.302258,"marketCap":1811232720},{"date":"2022-10-21","current":-5.299371,"twenty":-25.86293,"median":-13.634607,"eighty":-8.237937,"marketCap":1831357528},{"date":"2022-10-28","current":-5.250715,"twenty":-25.481615,"median":-13.551791,"eighty":-8.192941,"marketCap":1811232720},{"date":"2022-11-04","current":-5.746084,"twenty":-25.351843,"median":-13.359927,"eighty":-8.154695,"marketCap":1962168780},{"date":"2022-11-11","current":-5.443671,"twenty":-25.120629,"median":-13.222993,"eighty":-8.092767,"marketCap":1881669548},{"date":"2022-11-18","current":-5.72081,"twenty":-24.878607,"median":-13.14013,"eighty":-8.013993,"marketCap":1987047168},{"date":"2022-11-25","current":-5.519749,"twenty":-24.782531,"median":-13.026991,"eighty":-7.970562,"marketCap":1914602740},{"date":"2022-12-02","current":-5.340737,"twenty":-24.72503,"median":-13.016314,"eighty":-7.221843,"marketCap":1873205924},{"date":"2022-12-09","current":-5.278499,"twenty":-24.658883,"median":-12.887225,"eighty":-7.02693,"marketCap":1873205924},{"date":"2022-12-16","current":-5.377354,"twenty":-24.555217,"median":-12.861423,"eighty":-6.967635,"marketCap":1904253536},{"date":"2022-12-23","current":-5.310796,"twenty":-24.239903,"median":-12.809384,"eighty":-6.931658,"marketCap":1883555128},{"date":"2022-12-30","current":-5.2687,"twenty":-24.19825,"median":-12.751378,"eighty":-6.815448,"marketCap":1873205924},{"date":"2023-01-06","current":-5.684551,"twenty":-24.029078,"median":-12.691232,"eighty":-6.533241,"marketCap":2049142392},{"date":"2023-01-13","current":-6.044097,"twenty":-23.920542,"median":-12.610749,"eighty":-6.476414,"marketCap":2225078860},{"date":"2023-01-20","current":-5.920758,"twenty":-23.91098,"median":-12.476187,"eighty":-6.460592,"marketCap":2173332840},{"date":"2023-01-27","current":-5.929064,"twenty":-23.908935,"median":-12.464745,"eighty":-6.456521,"marketCap":2173332840},{"date":"2023-02-03","current":-5.619442,"twenty":-23.898059,"median":-12.438653,"eighty":-6.416304,"marketCap":2080190004},{"date":"2023-02-10","current":-5.629701,"twenty":-23.856379,"median":-12.391406,"eighty":-6.379809,"marketCap":2069840800},{"date":"2023-02-17","current":-6.151199,"twenty":-23.803856,"median":-12.342203,"eighty":-6.364619,"marketCap":2235428064},{"date":"2023-02-24","current":-5.880578,"twenty":-23.763812,"median":-12.319761,"eighty":-6.355094,"marketCap":2121586820},{"date":"2023-03-03","current":-5.79659,"twenty":-23.726876,"median":-12.282467,"eighty":-6.32688,"marketCap":2090539208},{"date":"2023-03-10","current":-5.984239,"twenty":-5.977251,"median":-5.862778,"eighty":-5.737999,"marketCap":2142285228},{"date":"2023-03-17","current":-5.440145,"twenty":-15.605451,"median":-11.818551,"eighty":-6.319247,"marketCap":1966348760},{"date":"2023-03-24","current":-5.852823,"twenty":-15.553476,"median":-11.796779,"eighty":-6.303621,"marketCap":1914602740},{"date":"2023-03-31","current":-5.770352,"twenty":-15.464387,"median":-11.782619,"eighty":-6.235793,"marketCap":1873205924},{"date":"2023-04-06","current":-6.188789,"twenty":-15.419813,"median":-11.775878,"eighty":-6.2298,"marketCap":2007745576},{"date":"2023-04-14","current":-5.83212,"twenty":-15.401098,"median":-11.743407,"eighty":-6.188789,"marketCap":1893904332},{"date":"2023-04-21","current":-5.803236,"twenty":-15.349971,"median":-11.591935,"eighty":-6.151199,"marketCap":1883555128},{"date":"2023-04-28","current":-5.97527,"twenty":-15.338346,"median":-11.514937,"eighty":-6.125749,"marketCap":1924951944},{"date":"2023-05-05","current":-6.029633,"twenty":-15.318487,"median":-11.456076,"eighty":-6.093971,"marketCap":1945650352},{"date":"2023-05-12","current":-5.845377,"twenty":-15.293441,"median":-11.42324,"eighty":-6.058678,"marketCap":1873205924},{"date":"2023-05-19","current":-5.895989,"twenty":-15.286763,"median":-11.409661,"eighty":-6.038289,"marketCap":1862856720},{"date":"2023-05-25","current":-5.986134,"twenty":-15.285108,"median":-11.402641,"eighty":-6.02786,"marketCap":1883555128},{"date":"2023-06-02","current":-6.039504,"twenty":-15.27892,"median":-11.345627,"eighty":-6.019397,"marketCap":1893904332},{"date":"2023-06-09","current":-5.916028,"twenty":-15.273247,"median":-11.325201,"eighty":-5.997341,"marketCap":1852507516},{"date":"2023-06-16","current":-5.977706,"twenty":-15.264367,"median":-11.276371,"eighty":-5.991274,"marketCap":1862856720},{"date":"2023-06-23","current":-5.910315,"twenty":-15.259114,"median":-11.226206,"eighty":-5.990104,"marketCap":1831809108},{"date":"2023-06-30","current":-5.997962,"twenty":-15.257471,"median":-11.199148,"eighty":-5.991102,"marketCap":1842158312},{"date":"2023-07-07","current":-5.942162,"twenty":-15.252204,"median":-11.17859,"eighty":-5.98564,"marketCap":1821459904},{"date":"2023-07-14","current":-5.959818,"twenty":-15.244629,"median":-11.155312,"eighty":-5.982549,"marketCap":1852507516},{"date":"2023-07-21","current":-5.653141,"twenty":-15.235372,"median":-11.133484,"eighty":-5.979215,"marketCap":1749015476},{"date":"2023-07-28","current":-5.290848,"twenty":-15.218265,"median":-11.083158,"eighty":-5.976244,"marketCap":1635174232},{"date":"2023-08-04","current":-5.34893,"twenty":-15.196364,"median":-11.056497,"eighty":-5.968485,"marketCap":1655872640},{"date":"2023-08-11","current":-4.874993,"twenty":-15.168558,"median":-11.029974,"eighty":-5.961311,"marketCap":1500634580},{"date":"2023-08-18","current":-4.808559,"twenty":-15.136918,"median":-11.016801,"eighty":-5.956293,"marketCap":1469586968},{"date":"2023-08-25","current":-4.590479,"twenty":-15.120821,"median":-10.958733,"eighty":-5.941162,"marketCap":1355745724},{"date":"2023-09-01","current":-4.397014,"twenty":-15.116519,"median":-10.950589,"eighty":-5.933791,"marketCap":1303999704},{"date":"2023-09-08","current":-4.343456,"twenty":-15.110458,"median":-10.924914,"eighty":-5.928982,"marketCap":1272952092},{"date":"2023-09-15","current":-4.239957,"twenty":-15.090079,"median":-10.864295,"eighty":-5.922195,"marketCap":1252253684},{"date":"2023-09-22","current":-4.223382,"twenty":-15.048512,"median":-10.810823,"eighty":-5.914373,"marketCap":1241904480},{"date":"2023-09-29","current":-4.216151,"twenty":-15.017245,"median":-10.782147,"eighty":-5.907939,"marketCap":1241904480},{"date":"2023-10-06","current":-4.112716,"twenty":-15.011235,"median":-10.698286,"eighty":-5.896366,"marketCap":1210856868},{"date":"2023-10-13","current":-3.837237,"twenty":-15.002346,"median":-10.647718,"eighty":-5.882039,"marketCap":1128063236},{"date":"2023-10-20","current":-4.160483,"twenty":-14.995938,"median":-10.633588,"eighty":-5.85882,"marketCap":1221206072},{"date":"2023-10-27","current":-3.950628,"twenty":-14.987484,"median":-10.612846,"eighty":-5.848271,"marketCap":1159110848},{"date":"2023-11-03","current":-3.869806,"twenty":-14.961935,"median":-10.544851,"eighty":-5.844462,"marketCap":1138412440},{"date":"2023-11-10","current":-3.835427,"twenty":-14.946362,"median":-10.425013,"eighty":-5.805638,"marketCap":1128063236},{"date":"2023-11-17","current":-4.010382,"twenty":-14.933379,"median":-10.337162,"eighty":-5.799605,"marketCap":1190158460},{"date":"2023-11-24","current":-4.150577,"twenty":-14.892592,"median":-10.317083,"eighty":-5.770352,"marketCap":1241904480},{"date":"2023-12-01","current":-4.305663,"twenty":-14.891221,"median":-10.26225,"eighty":-5.759604,"marketCap":1293650500},{"date":"2023-12-08","current":-5.118594,"twenty":-14.888832,"median":-10.236073,"eighty":-5.746084,"marketCap":1531682192},{"date":"2023-12-15","current":-5.983256,"twenty":-14.88193,"median":-10.184968,"eighty":-5.726275,"marketCap":1800761496},{"date":"2023-12-22","current":-6.021664,"twenty":-14.863859,"median":-10.158257,"eighty":-5.72081,"marketCap":1811110700},{"date":"2023-12-29","current":-5.750139,"twenty":-14.843956,"median":-10.132916,"eighty":-5.718706,"marketCap":1738666272},{"date":"2024-01-05","current":-5.68757,"twenty":-14.823059,"median":-10.050045,"eighty":-5.707969,"marketCap":1707618660},{"date":"2024-01-12","current":-6.094205,"twenty":-14.80664,"median":-10.01363,"eighty":-5.702385,"marketCap":1830679813},{"date":"2024-01-19","current":-5.813707,"twenty":-14.792628,"median":-10.010505,"eighty":-5.707969,"marketCap":1744020413},{"date":"2024-01-26","current":-5.727669,"twenty":-14.770095,"median":-9.994578,"eighty":-5.702385,"marketCap":1711523138},{"date":"2024-02-02","current":-5.121562,"twenty":-14.746641,"median":-9.9689,"eighty":-5.687475,"marketCap":1528457166},{"date":"2024-02-09","current":-5.096464,"twenty":-14.734149,"median":-9.944662,"eighty":-5.662686,"marketCap":1528457166},{"date":"2024-02-16","current":-5.240944,"twenty":-14.725283,"median":-9.913368,"eighty":-5.653616,"marketCap":1572127371},{"date":"2024-02-23","current":-5.085778,"twenty":-14.723007,"median":-9.893442,"eighty":-5.639193,"marketCap":1517539615},{"date":"2024-03-01","current":-5.009476,"twenty":-14.664467,"median":-9.865328,"eighty":-5.60727,"marketCap":1495704513},{"date":"2024-03-08","current":-5.007249,"twenty":-14.62577,"median":-9.833927,"eighty":-5.587439,"marketCap":1495704513},{"date":"2024-03-15","current":-4.865359,"twenty":-14.61207,"median":-9.76953,"eighty":-5.567433,"marketCap":1452034308},{"date":"2024-03-22","current":-5.382425,"twenty":-14.606007,"median":-9.684863,"eighty":-5.542667,"marketCap":1604880024},{"date":"2024-03-28","current":-6.471617,"twenty":-14.596766,"median":-9.6313,"eighty":-5.538679,"marketCap":1703137985},{"date":"2024-04-05","current":-6.805541,"twenty":-14.59363,"median":-9.596323,"eighty":-5.544948,"marketCap":1790478395},{"date":"2024-04-12","current":-7.506731,"twenty":-14.592289,"median":-9.582636,"eighty":-5.549891,"marketCap":1976076765},{"date":"2024-04-19","current":-7.845218,"twenty":-14.587772,"median":-9.509145,"eighty":-5.557524,"marketCap":2063417174},{"date":"2024-04-26","current":-7.896463,"twenty":-14.578925,"median":-9.436926,"eighty":-5.566301,"marketCap":2074334726},{"date":"2024-05-03","current":-7.860336,"twenty":-14.573204,"median":-9.382005,"eighty":-5.567444,"marketCap":2063417174},{"date":"2024-05-10","current":-7.675757,"twenty":-14.563974,"median":-9.240993,"eighty":-5.569089,"marketCap":2019746970},{"date":"2024-05-17","current":-7.396179,"twenty":-14.56342,"median":-9.187914,"eighty":-5.575495,"marketCap":1943324111},{"date":"2024-05-24","current":-8.037809,"twenty":-14.531177,"median":-9.069449,"eighty":-5.582295,"marketCap":2107087379},{"date":"2024-05-31","current":-7.738407,"twenty":-14.480405,"median":-8.990305,"eighty":-5.587439,"marketCap":2030664521},{"date":"2024-06-07","current":-7.248143,"twenty":-14.467448,"median":-8.924233,"eighty":-5.592398,"marketCap":1899653907},{"date":"2024-06-14","current":-7.171402,"twenty":-14.419922,"median":-8.847943,"eighty":-5.59554,"marketCap":1877818804},{"date":"2024-06-21","current":-6.935757,"twenty":-14.35206,"median":-8.704335,"eighty":-5.604323,"marketCap":1812313497},{"date":"2024-06-28","current":-7.022233,"twenty":-14.336471,"median":-8.492709,"eighty":-5.607081,"marketCap":1834148599},{"date":"2024-07-05","current":-6.856527,"twenty":-14.328858,"median":-8.376987,"eighty":-5.611504,"marketCap":1790478395},{"date":"2024-07-12","current":-7.013456,"twenty":-14.30467,"median":-8.326629,"eighty":-5.617396,"marketCap":1834148599},{"date":"2024-07-19","current":-6.554119,"twenty":-14.290694,"median":-8.30121,"eighty":-5.625597,"marketCap":1714055536},{"date":"2024-07-26","current":-6.654635,"twenty":-14.285804,"median":-8.255353,"eighty":-5.635396,"marketCap":1746808190},{"date":"2024-08-02","current":-6.783362,"twenty":-14.277131,"median":-8.215302,"eighty":-5.643728,"marketCap":1779560843},{"date":"2024-08-09","current":-6.614431,"twenty":-14.234116,"median":-8.193349,"eighty":-5.650585,"marketCap":1746808190},{"date":"2024-08-16","current":-6.446564,"twenty":-14.191312,"median":-8.188382,"eighty":-5.653141,"marketCap":1703137985},{"date":"2024-08-23","current":-6.56458,"twenty":-14.177716,"median":-8.149928,"eighty":-5.653426,"marketCap":1430199205},{"date":"2024-08-30","current":-6.321694,"twenty":-14.158701,"median":-8.105511,"eighty":-5.655741,"marketCap":1386529001},{"date":"2024-09-06","current":-5.721612,"twenty":-14.142552,"median":-8.055097,"eighty":-5.660287,"marketCap":1255518386},{"date":"2024-09-13","current":-6.085816,"twenty":-14.137983,"median":-8.032869,"eighty":-5.662843,"marketCap":1331941245},{"date":"2024-09-20","current":-6.099124,"twenty":-14.136128,"median":-8.002056,"eighty":-5.663724,"marketCap":1342858796},{"date":"2024-09-27","current":-6.111953,"twenty":-14.132785,"median":-7.980325,"eighty":-5.672567,"marketCap":1353776347},{"date":"2024-10-04","current":-6.090326,"twenty":-14.125857,"median":-7.967369,"eighty":-5.685123,"marketCap":1342858796},{"date":"2024-10-10","current":-6.825013,"twenty":-14.110707,"median":-7.909429,"eighty":-5.687411,"marketCap":1495704513},{"date":"2024-10-18","current":-6.96373,"twenty":-14.109239,"median":-7.894808,"eighty":-5.68757,"marketCap":1517539615},{"date":"2024-10-25","current":-6.863968,"twenty":-14.101553,"median":-7.887625,"eighty":-5.688686,"marketCap":1495704513},{"date":"2024-11-01","current":-6.258525,"twenty":-14.091231,"median":-7.876326,"eighty":-5.702032,"marketCap":1364693898},{"date":"2024-11-08","current":-6.154956,"twenty":-14.089073,"median":-7.847489,"eighty":-5.702032,"marketCap":1331941245},{"date":"2024-11-15","current":-5.89682,"twenty":-14.011082,"median":-7.738407,"eighty":-5.702032,"marketCap":1266435938},{"date":"2024-11-22","current":-5.696759,"twenty":-13.916278,"median":-7.696764,"eighty":-5.696759,"marketCap":1222765733},{"date":"2024-11-29","current":-5.394645,"twenty":-13.832055,"median":-7.596958,"eighty":-5.664577,"marketCap":1157260426},{"date":"2024-12-06","current":-5.458395,"twenty":-13.711835,"median":-7.485856,"eighty":-5.653616,"marketCap":1168177977},{"date":"2024-12-13","current":-5.673645,"twenty":-13.553001,"median":-7.352815,"eighty":-5.653141,"marketCap":1211848182},{"date":"2024-12-20","current":-5.390849,"twenty":-13.519899,"median":-7.248143,"eighty":-5.614983,"marketCap":1146342874},{"date":"2024-12-27","current":-5.65194,"twenty":-13.458044,"median":-7.171402,"eighty":-5.614326,"marketCap":1200930630},{"date":"2025-01-03","current":-5.184433,"twenty":-13.405799,"median":-7.104086,"eighty":-5.600887,"marketCap":1102672670},{"date":"2025-01-10","current":-5.152626,"twenty":-13.361795,"median":-7.069649,"eighty":-5.582295,"marketCap":1091755119},{"date":"2025-01-17","current":-5.148471,"twenty":-13.336569,"median":-7.026933,"eighty":-5.552175,"marketCap":1091755119},{"date":"2025-01-24","current":-5.167576,"twenty":-13.222993,"median":-7.013456,"eighty":-5.514572,"marketCap":1102672670},{"date":"2025-01-28","current":-5.140636,"twenty":-13.208359,"median":-6.990621,"eighty":-5.503528,"marketCap":1102672670},{"date":"2025-02-07","current":-5.27226,"twenty":-13.135783,"median":-6.94846,"eighty":-5.495097,"marketCap":1124507772},{"date":"2025-02-14","current":-5.644048,"twenty":-13.022037,"median":-6.899379,"eighty":-5.48863,"marketCap":1200930630},{"date":"2025-02-21","current":-5.307084,"twenty":-12.940412,"median":-6.85645,"eighty":-5.475956,"marketCap":1135425323},{"date":"2025-02-28","current":-5.939013,"twenty":-12.867839,"median":-6.83647,"eighty":-5.468291,"marketCap":1266435938},{"date":"2025-03-07","current":-6.119239,"twenty":-12.809466,"median":-6.804007,"eighty":-5.467568,"marketCap":1310106142},{"date":"2025-03-14","current":-5.964088,"twenty":-12.763824,"median":-6.770661,"eighty":-5.467568,"marketCap":1277353489},{"date":"2025-03-21","current":-6.272401,"twenty":-12.722881,"median":-6.714298,"eighty":-5.467568,"marketCap":1342858796},{"date":"2025-03-28","current":-6.898302,"twenty":-12.722881,"median":-6.670615,"eighty":-5.467568,"marketCap":1473869410},{"date":"2025-04-03","current":-7.011472,"twenty":-12.722881,"median":-6.642295,"eighty":-5.467568,"marketCap":1386529001},{"date":"2025-04-11","current":-6.280275,"twenty":-12.722881,"median":-6.610673,"eighty":-5.467568,"marketCap":1233683284},{"date":"2025-04-17","current":-6.819691,"twenty":-12.721837,"median":-6.592748,"eighty":-5.468291,"marketCap":1342858796},{"date":"2025-04-25","current":-7.256981,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1430199205},{"date":"2025-05-02","current":-8.73413,"twenty":-12.722881,"median":-6.57172,"eighty":-5.467568,"marketCap":1724973088},{"date":"2025-05-09","current":-7.136212,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1419281654},{"date":"2025-05-16","current":-7.078383,"twenty":-12.723926,"median":-6.571402,"eighty":-5.466844,"marketCap":1419281654},{"date":"2025-05-23","current":-6.948699,"twenty":-12.626269,"median":-6.571402,"eighty":-5.466844,"marketCap":1397446552},{"date":"2025-05-30","current":-7.999265,"twenty":-12.463363,"median":-6.56664,"eighty":-5.466844,"marketCap":1615797576},{"date":"2025-06-06","current":-12.669712,"twenty":-12.457434,"median":-6.56664,"eighty":-5.466844,"marketCap":2565725443},{"date":"2025-06-13","current":-14.210631,"twenty":-12.612398,"median":-6.56664,"eighty":-5.466844,"marketCap":2878912587},{"date":"2025-06-20","current":-12.510851,"twenty":-12.558798,"median":-6.56664,"eighty":-5.466844,"marketCap":2529588465},{"date":"2025-06-27","current":-11.34714,"twenty":-12.552983,"median":-6.5687,"eighty":-5.467568,"marketCap":2300720937},{"date":"2025-07-04","current":-12.118889,"twenty":-12.471396,"median":-6.5687,"eighty":-5.467568,"marketCap":2457314509},{"date":"2025-07-11","current":-11.95271,"twenty":-12.404868,"median":-6.5687,"eighty":-5.467568,"marketCap":2421177531},{"date":"2025-07-18","current":-15.651881,"twenty":-12.404868,"median":-6.5687,"eighty":-5.467568,"marketCap":3168008411},{"date":"2025-07-25","current":-19.153,"twenty":-12.471396,"median":-6.5687,"eighty":-5.467568,"marketCap":3890747973},{"date":"2025-08-01","current":-18.615757,"twenty":-12.640326,"median":-6.5687,"eighty":-5.467568,"marketCap":3758245720},{"date":"2025-08-08","current":-17.200416,"twenty":-12.738412,"median":-6.5687,"eighty":-5.467568,"marketCap":3481195555},{"date":"2025-08-15","current":-21.041033,"twenty":-12.774326,"median":-6.5687,"eighty":-5.467568,"marketCap":4252117754},{"date":"2025-08-22","current":-18.790719,"twenty":-12.888016,"median":-6.5687,"eighty":-5.467568,"marketCap":3785450762},{"date":"2025-08-29","current":-15.943312,"twenty":-13.023275,"median":-6.5687,"eighty":-5.467568,"marketCap":3227164858},{"date":"2025-09-05","current":-20.757694,"twenty":-13.176303,"median":-6.5687,"eighty":-5.467568,"marketCap":3272466472},{"date":"2025-09-12","current":-15.628094,"twenty":-13.244692,"median":-6.5687,"eighty":-5.467568,"marketCap":2468216238},{"date":"2025-09-19","current":-16.869242,"twenty":-13.354631,"median":-6.5687,"eighty":-5.467568,"marketCap":2662345605},{"date":"2025-09-26","current":-15.503696,"twenty":-13.402244,"median":-6.5687,"eighty":-5.467568,"marketCap":2440483471},{"date":"2025-10-03","current":-16.433457,"twenty":-13.441102,"median":-6.569892,"eighty":-5.468291,"marketCap":2593013688},{"date":"2025-10-10","current":-15.577362,"twenty":-13.522687,"median":-6.5687,"eighty":-5.467568,"marketCap":2454349854},{"date":"2025-10-17","current":-13.739896,"twenty":-13.565862,"median":-6.5687,"eighty":-5.467568,"marketCap":2163155804},{"date":"2025-10-24","current":-13.558813,"twenty":-13.693116,"median":-6.5687,"eighty":-5.467568,"marketCap":2135423037},{"date":"2025-10-31","current":-14.329838,"twenty":-13.753461,"median":-6.5687,"eighty":-5.467568,"marketCap":2260220487},{"date":"2025-11-07","current":-14.426762,"twenty":-13.841138,"median":-6.5687,"eighty":-5.467568,"marketCap":2274086871},{"date":"2025-11-14","current":-15.78951,"twenty":-13.942615,"median":-6.5687,"eighty":-5.467568,"marketCap":2495949004},{"date":"2025-11-21","current":-14.129422,"twenty":-14.006324,"median":-6.5687,"eighty":-5.467568,"marketCap":2232487720},{"date":"2025-11-28","current":-13.378743,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2121556654},{"date":"2025-12-05","current":-13.181195,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2093823887},{"date":"2025-12-12","current":-13.069727,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2079957504},{"date":"2025-12-19","current":-12.865144,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2052224737},{"date":"2025-12-24","current":-12.825196,"twenty":-14.010005,"median":-6.5687,"eighty":-5.467568,"marketCap":2052224737},{"date":"2026-01-02","current":-11.998065,"twenty":-14.010364,"median":-6.56664,"eighty":-5.466844,"marketCap":1927427287},{"date":"2026-01-09","current":-14.723549,"twenty":-14.053942,"median":-6.56664,"eighty":-5.466844,"marketCap":2371151554},{"date":"2026-01-16","current":-12.358616,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1996759203},{"date":"2026-01-23","current":-12.370484,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1996759203},{"date":"2026-01-30","current":-11.630068,"twenty":-14.084528,"median":-6.56664,"eighty":-5.466844,"marketCap":1885828136},{"date":"2026-02-06","current":-14.244909,"twenty":-14.090415,"median":-6.56664,"eighty":-5.466844,"marketCap":2315686021},{"date":"2026-02-13","current":-16.029413,"twenty":-14.132571,"median":-6.5687,"eighty":-5.467568,"marketCap":2620746455},{"date":"2026-02-20","current":-16.98681,"twenty":-14.145589,"median":-6.56458,"eighty":-5.466121,"marketCap":2773276672},{"date":"2026-02-27","current":-16.970561,"twenty":-14.207782,"median":-6.56458,"eighty":-5.466121,"marketCap":2801009438},{"date":"2026-03-06","current":-16.515615,"twenty":-14.281053,"median":-6.56458,"eighty":-5.466121,"marketCap":2703944755},{"date":"2026-03-13","current":-14.500832,"twenty":-14.334826,"median":-6.56458,"eighty":-5.466121,"marketCap":2385017937},{"date":"2026-03-20","current":-14.302066,"twenty":-14.404725,"median":-6.56458,"eighty":-5.466121,"marketCap":2343418787},{"date":"2026-03-27","current":-20.530075,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2440483471},{"date":"2026-04-02","current":-20.431884,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2440483471},{"date":"2026-04-10","current":-18.777882,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2260220487},{"date":"2026-04-17","current":-18.194234,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2190888570},{"date":"2026-04-24","current":-17.041733,"twenty":-14.383506,"median":-6.56458,"eighty":-5.466121,"marketCap":2052224737},{"date":"2026-04-30","current":-17.267598,"twenty":-14.418248,"median":-6.56458,"eighty":-5.466121,"marketCap":2079957504},{"date":"2026-05-08","current":-16.290118,"twenty":-14.467448,"median":-6.563413,"eighty":-5.465398,"marketCap":1969026437},{"date":"2026-05-15","current":-14.988785,"twenty":-14.531177,"median":-6.563413,"eighty":-5.465398,"marketCap":1816496220},{"date":"2026-05-22","current":-15.481839,"twenty":-14.571639,"median":-6.56458,"eighty":-5.466121,"marketCap":1871961753},{"date":"2026-05-29","current":-14.171079,"twenty":-14.581223,"median":-6.563413,"eighty":-5.465398,"marketCap":1719431536},{"date":"2026-06-05","current":-13.465839,"twenty":-14.581223,"median":-6.563413,"eighty":-5.465398,"marketCap":1636233236},{"date":"2026-06-12","current":-14.731093,"twenty":-14.59239,"median":-6.563413,"eighty":-5.465398,"marketCap":1788763453},{"date":"2026-06-18","current":-13.218654,"twenty":-14.59234,"median":-6.56458,"eighty":-5.466121,"marketCap":1608500469},{"date":"2026-06-26","current":-11.448026,"twenty":-14.59239,"median":-6.563413,"eighty":-5.465398,"marketCap":1386638336},{"date":"2026-07-03","current":-14.871309,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1802629836},{"date":"2026-07-10","current":-13.629694,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1650099619},{"date":"2026-07-17","current":-12.782457,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1553034936},{"date":"2026-07-24","current":-13.692413,"twenty":-14.594456,"median":-6.563413,"eighty":-5.465398,"marketCap":1663966003},{"date":"2026-07-31","current":-15.488645,"twenty":-14.607478,"median":-6.562246,"eighty":-5.465196,"marketCap":1885828136},{"date":"2026-08-07","current":-15.231297,"twenty":-14.723549,"median":-6.562246,"eighty":-5.465196,"marketCap":1858095370},{"date":"2026-08-11","current":-14.423838,"twenty":-14.723694,"median":-6.562246,"eighty":-5.465196,"marketCap":1761030686}],"updateTime":1786512547387},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03681\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1138145796","title":"Revised Title","url":"https://stock-news.laohu8.com/highlight/detail?id=1138145796","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138145796?lang=en_us&edition=fundamental","pubTime":"2026-05-14 19:18","pubTimestamp":1778757531,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) Presents Preclinical Findings for Anti-CGC Antibody (hC2) at 2026 SID Annual Meeting","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","BK4557","BK4007","CGC","BK1161","03681","BK1574","SID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111519083","title":"Sinomab Bioscience posts unchanged share capital and maintains public float in April 2026 monthly return","url":"https://stock-news.laohu8.com/highlight/detail?id=1111519083","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111519083?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:05","pubTimestamp":1778058301,"startTime":"0","endTime":"0","summary":"Sinomab Bioscience Limited released its Monthly Return for the period ended 30 April 2026, confirming a stable share structure and continued compliance with Hong Kong Stock Exchange public-float...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630437364","title":"SinoMab BioScience releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630437364","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630437364?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:50","pubTimestamp":1777283414,"startTime":"0","endTime":"0","summary":"SinoMab issued its 2025 ESG report covering operations in Chinese Mainland and Hong Kong, with environmental KPIs focused on Hainan, Suzhou, and Hong Kong.Board set environmental operating targets, reviewed progress during year, signed off ESG disclosures on March 23, 2026.Workforce fell to 66 at Dec. 31, 2025 from 95 a year earlier, linked to restructuring tied to partial suspension of operations.Electricity consumption dropped about 74% year on year, driven by energy-saving measures, reduced activity.Group flagged no material regulatory breaches across product responsibility, anti-corruption, workplace safety, or environmental compliance during reporting period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL85LnTV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161634817","title":"SinoMab BioScience unveils 2026 AGM agenda: board changes, 10% share buy-back mandate and 20% issuance limit","url":"https://stock-news.laohu8.com/highlight/detail?id=1161634817","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161634817?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:43","pubTimestamp":1777283036,"startTime":"0","endTime":"0","summary":"28 April 2026 – SinoMab BioScience Limited (SinoMab Bio-B, 03681) has dispatched a circular convening its 2026 Annual General Meeting for 12 June 2026, 10:00 a.m., at Fairmont House, Central, Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630361091","title":"SinoMab BioScience announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630361091","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630361091?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:36","pubTimestamp":1777282594,"startTime":"0","endTime":"0","summary":"SinoMab BioScience will hold its annual general meeting in Central, Hong Kong on June 12, 2026.Shareholders will receive audited consolidated financial statements for year ended Dec. 31, 2025.Resolutions include re-election of four directors, election of Lei Xue as non-executive director for a three-year term, and authorization for board to set directors’ remuneration.Meeting will vote on re-appointment of Ernst & Young as auditor.Proposals include share buyback mandate up to 10% of issued shares excluding treasury shares, share issuance mandate up to 20%, and an extension linking the issuance mandate to shares repurchased.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to gen","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLJBt6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630612513","title":"SinoMab BioScience publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630612513","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630612513?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:32","pubTimestamp":1777282328,"startTime":"0","endTime":"0","summary":"SinoMab BioScience annual report for year ended Dec. 31, 2025, highlighted SM17 Phase 1b topline data in China for moderate-to-severe atopic dermatitis, with 91.7% of high-dose patients achieving NRS-4 pruritus relief.Clinical execution shifted toward broader development, with SM17 subcutaneous bridging study dosing started in October 2025, then follow-up for 30 healthy subjects completed in February 2026.Strategic focus moved away from rheumatoid arthritis registration for SM03 , with BLA voluntarily withdrawn on July 14, 2025, as development pivoted toward systemic lupus erythematosus.Manufacturing strategy tilted to an asset-light model, with Haikou production-base lease termination agreed post period, while Suzhou campus secured real estate ownership certificate in March 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL3kbNk6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137794179","title":"君实生物（SINOMAB BIO-B）2025年显著减亏，股本增长强化资金实力","url":"https://stock-news.laohu8.com/highlight/detail?id=1137794179","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137794179?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:27","pubTimestamp":1777282070,"startTime":"0","endTime":"0","summary":"君实生物（SINOMAB BIO-B，股份代号：03681）公布截至2025年12月31日止年度的综合财务及业务表现，报告期内尽管仍未实现收入，研发投入和经营亏损均有所收窄，股本与流动资金状况大幅提升。公司继续深化免疫学领域创新研发，推进主要在研管线的多适应症布局，并加快与外部伙伴的合作与产能整合。 ▌全年业绩与财务状况...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"君实生物（SINOMAB BIO-B）2025年显著减亏，股本增长强化资金实力","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127081164","title":"Sinomab Bioscience Maintains 1.39 Billion Outstanding Shares in March 2026, Grants 11.57 Million New Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1127081164","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127081164?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:22","pubTimestamp":1775640146,"startTime":"0","endTime":"0","summary":"Sinomab Bioscience Limited reported no change in its share capital for the month ended 31 March 2026. The number of issued ordinary shares remained at 1.39 billion, and the company held no treasury...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624688186","title":"BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience","url":"https://stock-news.laohu8.com/highlight/detail?id=2624688186","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624688186?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:31","pubTimestamp":1775223071,"startTime":"0","endTime":"0","summary":"BRIEF-Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience  April 3 (Reuters) - Hainan Haiyao Co Ltd 000566.SZ:SAYS CO PLANS TO UNLOAD UP TO 5% STAKE IN SINOMAB BIOSCIENCE LTDSource textFurther company coverage: 000566.SZ (Reporting by Beijing Newsroom) ((Shi.Bu@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nL4N40M0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0146","03681","BK0060","BK1161","000566","BK0239","BK1574","BK0188","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624668891","title":"Hainan Haiyao  Says Co Plans to Unload up to 5% Stake in SinoMab BioScience Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2624668891","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624668891?lang=en_us&edition=fundamental","pubTime":"2026-04-03 21:31","pubTimestamp":1775223071,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nL4N40M0E2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK0070","000566","BK1161","BK0188","03681","BK0060","BK0239","BK0146"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116443811","title":"SM17 Phase 2 Trial for Atopic Dermatitis Administers First Dose in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1116443811","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116443811?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:54","pubTimestamp":1775037289,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that on March 31, 2026, the first patient in its Phase 2 clinical trial for SM17 in treating atopic dermatitis was successfully dosed in China. This Phase 2 study...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591953","title":"SinoMab doses first patient in China Phase 2 trial of SM17 for atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591953","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624591953?lang=en_us&edition=fundamental","pubTime":"2026-04-01 17:47","pubTimestamp":1775036857,"startTime":"0","endTime":"0","summary":"SinoMab BioScience dosed first patient on March 31, 2026 in a Phase 2 China trial of SM17 for moderate-to-severe atopic dermatitis.Study will test subcutaneous SM17 across multiple dose groups versus placebo in about 210 patients, with readouts planned through Week 24.Program follows previously presented positive Phase 1b topline results in atopic dermatitis, supporting continued development for both itch relief and skin improvement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL6dPlN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","03681","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624584965","title":"SinoMab BioScience says non-executive directors Chen, Dong resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2624584965","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624584965?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:59","pubTimestamp":1774990769,"startTime":"0","endTime":"0","summary":"SinoMab BioScience said non-executive director Haigang Chen will step down effective March 31, 2026.Non-executive director Xun Dong will resign effective April 1, 2026.Board will retain Shui On Leung as executive director, chairman, and CEO.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLcb3DmH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624452558","title":"SinoMab BioScience files list of directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2624452558","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624452558?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:58","pubTimestamp":1774990717,"startTime":"0","endTime":"0","summary":"SinoMab BioScience filed updated board composition for Hong Kong Stock Exchange, naming Shui On Leung as chairman and chief executive officer.Board includes two non-executive directors, including Xun Dong.Board includes five independent non-executive directors, including Ping Cho Terence Hon.Hon chairs audit committee; Chi Ming Lee chairs remuneration committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SinoMab BioScience Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 31, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLHTsdT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","03681","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175147246","title":"SinoMab Announces Resignation of Two Non-Executive Directors Effective March–April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1175147246","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175147246?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:27","pubTimestamp":1774952869,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited reported that non-executive directors Dr. Haigang Chen and Mr. Xun Dong have submitted their resignations, citing personal and business commitments. Dr. Chen’s resignation...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170105062","title":"SinoMab Announces Updated Board Composition and Committee Assignments","url":"https://stock-news.laohu8.com/highlight/detail?id=1170105062","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170105062?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:23","pubTimestamp":1774952635,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited disclosed an updated roster of its Board of Directors, highlighting current roles and committee memberships as of 31 March 2026. The Board now comprises one executive...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107449274","title":"SINOMAB BIO-B Announces Resignation of Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1107449274","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107449274?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:07","pubTimestamp":1774951661,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that Dr. Chen Haigang has submitted his resignation as a non-executive director, effective March 31, 2026, in order to devote more time to personal matters....","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102149296","title":"SinoMab Announces Positive Phase 1 Bridging Data for Subcutaneous SM17, Preparing Phase 2 Atopic Dermatitis Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1102149296","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102149296?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:03","pubTimestamp":1774432989,"startTime":"0","endTime":"0","summary":"SinoMab BioScience Limited disclosed encouraging topline results from a Phase 1 bridging study assessing the subcutaneous (SC) formulation of its first-in-class monoclonal antibody SM17 in mainland...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186285600","title":"Positive Topline Results from SM17 Route Conversion Phase 1 Bridging Study in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1186285600","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186285600?lang=en_us&edition=fundamental","pubTime":"2026-03-25 18:01","pubTimestamp":1774432870,"startTime":"0","endTime":"0","summary":"SINOMAB BIO-B (03681) has announced that its SM17 drug candidate has achieved positive topline results in a Phase 1 bridging study in China evaluating a route of administration conversion. The first...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","03681"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622021012","title":"SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2622021012","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622021012?lang=en_us&edition=fundamental","pubTime":"2026-03-25 17:51","pubTimestamp":1774432301,"startTime":"0","endTime":"0","summary":"SinoMab BioScience announces positive topline results for SM17 China Phase 1 route-switch bridging study; AD Phase 2 in China expected to start by mid-FY2026. SinoMab BioScience reported positive topline results from a China Phase 1 bridging study that supports switching SM17 to a subcutaneous formulation, a step that could improve convenience and strengthen its positioning in inflammatory and immune diseases.The randomized, double-blind, placebo-controlled trial enrolled 30 healthy participants and reported no serious adverse events, while injection-site reactions were limited to one Grade 1 rash that resolved within one hour.The company said the subcutaneous formulation showed predictable pharmacokinetics and competitive absolute bioavailability, supporting a stable route-of-administration transition and potentially broadening commercialization options.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL43HMBh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03681","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":59,"code":"91000000","status":"200"}]}}